Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
25,49 USD | -1,05% |
|
+8,42% | +18,45% |
Attività
Numero di dipendenti: 30
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Human Enzyme Therapeutics
100,0
%
| 2 | 100,0 % | 1 | 100,0 % | -61,96% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 1 | 100,0 % | -61,96% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Cameron Turtle
CEO | Chief Executive Officer | 34 | 22/06/23 |
Scott Burrows
DFI | Director of Finance/CFO | 47 | 01/09/23 |
Brian Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 27/11 |
Chief Tech/Sci/R&D Officer | 56 | 01/02/14 | |
MiRa Huyghe
PRN | Corporate Officer/Principal | - | 27/11 |
Deanna Nguyen
PRN | Corporate Officer/Principal | - | 27/11 |
Joshua Friedman
PRN | Corporate Officer/Principal | - | 27/11 |
General Counsel | 41 | 05/09/23 | |
Paul Fehlner
PRN | Corporate Officer/Principal | 61 | 27/11 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Tomas Kiselak
BRD | Director/Board Member | 37 | 22/06/23 |
Jeffrey Albers
BRD | Director/Board Member | 52 | 27/11 |
Peter Harwin
BRD | Director/Board Member | 38 | 22/06/23 |
Laurie Stelzer
BRD | Director/Board Member | 56 | 27/11 |
Director/Board Member | 34 | 22/06/23 | |
Mark Mckenna
BRD | Director/Board Member | 44 | 01/02 |
Cameron Turtle
CEO | Chief Executive Officer | 34 | 22/06/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 271 625 | 0 | 0 | 91,03 % |
Azione B | 1 | 50 782 384 | 46 228 009 ( 91,03 %) | 0 | |
Azione C | 0 | 437 037 | 0 | 0 |
Coordinate società
Spyre Therapeutics, Inc.
Building 17 221 Crescent Street
02453, Waltham
+617 651 5940
http://www.aeglea.com![Indirizzo Spyre Therapeutics, Inc.(SYRE)](https://cdn.zonebourse.com/static/address/27114072.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+18,45% | 1,29 Mrd | |
+16,61% | 122 Mrd | |
+17,75% | 112 Mrd | |
+17,23% | 25,91 Mrd | |
-24,11% | 19,33 Mrd | |
-18,56% | 16,17 Mrd | |
-18,47% | 15,56 Mrd | |
-47,75% | 14,65 Mrd | |
+57,35% | 14,34 Mrd | |
+5,62% | 14 Mrd |
- Borsa valori
- Azioni
- Azione SYRE
- Società Spyre Therapeutics, Inc.